Fingerprint
Dive into the research topics of 'Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
Carl Regillo, Brian Berger, Logan Brooks, W. Lloyd Clark, Robert Mittra, Charles C. Wykoff, Natalia F. Callaway, Stephanie DeGraaf, Han Ting Ding, Anne E. Fung, Shamika Gune, Sophie Le Pogam, Robert Smith, Jeffrey R. Willis, Giulio Barteselli
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations